Codice QR

Repurposing of Rutan showed effective treatment for COVID-19 disease

Previously, from the tannic sumac plant (Rhus coriaria), we developed the Rutan 25 mg oral drug tablets with antiviral activity against influenza A and B viruses, adenoviruses, paramyxoviruses, herpes virus, and cytomegalovirus. Here, our re-purposing study demonstrated that Rutan at 25, 50, and 100...

Descrizione completa

Salvato in:
Autori principali: Shavkat I. Salikhov, Ibrokhim Y. Abdurakhmonov, Yuliya I. Oshchepkova, Jamolitdin F. Ziyavitdinov, Nodir Sh. Berdiev, Haji Akber Aisa, Jingshan Shen, Yechun Xu, H. Eric Xu, Xiangrui Jiang, Leike Zhang, Natalia L. Vypova, Dilshod Sh. Allaberganov, Nigora A. Tagayalieva, Erkin I. Musabaev, Gulnara A. Ibadova, Ilxom B. Rajabov, Lyubov M. Lokteva
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2023-11-01
Serie:Frontiers in Medicine
Soggetti:
COVID-19
SARS-CoV-2
3CLpro
RdRp
Rhus coriaria
Rutan
Accesso online:https://www.frontiersin.org/articles/10.3389/fmed.2023.1310129/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi